Buys
Open market- Shares
- Avg price
- Total value
Luke Evnin - Director at Werewolf Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- HOWL on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Luke Evnin in Werewolf Therapeutics, Inc.
Sells
Open market- Shares
- -4,309,860
- Avg price
- $0.7554
- Total value
- -$3,255,559
Net
Past year- Shares
- -4,309,860
- Share %
- -100%
- Total value
- -$3,255,559
Reported holdings for Luke Evnin in Werewolf Therapeutics, Inc.
Form 4 holding
Director
Werewolf Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 07 Jul 2026
- Price
- $0.3100
- Ownership
- Indirect
Form 4 holding
Director
Werewolf Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 27,000
- Estimated value
- Report date
- 12 Jun 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Werewolf Therapeutics, Inc.
- Security class
- Warrant (Right to Buy)
- Shares / value
- 0
- Estimated value
- Report date
- 27 Mar 2025
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Luke Evnin in Werewolf Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.